Boehringer Ingelheim at SLAS2027

Jan 30 – Feb 3, 2027 San Diego, CA ~7.6k attendees Website

Boehringer Ingelheim brings 1 presentation to SLAS2027 in San Diego. Its talk presents a label-free real-time cell analysis platform for GPCR hit discovery and validation.

OrganizationSLAS2027 Attendance
Boehringer Ingelheim
Ingelheim, Germany
Biopharma
Family-owned pharmaceutical company developing human medicines and animal health products.
Talk
Wed Feb 3
2:30–2:55pm
Part of Advances in Chemical Biology for Mechanistic Insights
A Label-Free RTCA Platform for GPCR Hit Discovery and Orthogonal Hit Validation
Ballroom 6D
Assay development and screening

Explore the full SLAS2027 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in San Diego. Leave your work email and we’ll be in touch.

Privacy

Download the full SLAS2027 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Find decision makers at Boehringer Ingelheim

Tell us what you sell and we’ll find the people at Boehringer Ingelheim most likely to buy it.

  • Who to contact
  • Their contact info
  • What to say
  • Free, no sign-up

Not affiliated with the Society for Laboratory Automation and Screening. Organization details are derived from SLAS’s published exhibitor list and event scheduler. Submit a correction